Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

TNXPTNXP
6 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in TONIX PHARMACEUTICALS HLDG C

Yes. Geode Capital Management holds 395,260 shares of TNXP (Tonix Pharmaceuticals), worth $5M, as of its Q2 2026 13F filing. It increased the position by 81,969 shares (+26.2%) from Q1 2026. Geode Capital Management has held TNXP since Q1 2025, across 6 quarterly 13F filings.

Current Value

$5M

Current Shares

395,260

Total Value Change

+$3.9M

Total Shares Change

+333,223

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
395,260
+26.2%
$5M0.0%$12.76
33
2026-Q1
Increased
313,291
+15.2%
$4.3M0.0%$13.75
31
2025-Q4
Increased
271,904
+35.3%
$4.2M0.0%$15.62
35
2025-Q3
Increased
200,934
+14.7%
$4.9M0.0%$24.16
31
2025-Q2
Increased
175,212
+182.4%
$6.3M0.0%$35.98
44
2025-Q1
New
62,037
-
$1.1M0.0%$17.88
35

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used